[Federal Register Volume 84, Number 78 (Tuesday, April 23, 2019)]
[Notices]
[Pages 16865-16867]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-08149]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60-Day-19-19ACC; Docket No. CDC-2019-0020]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Survey of Engineered Nanomaterial
Occupational Safety and Health Practices. The goal of this project is
to assess the relevance and impact of NIOSH's contribution to
guidelines and risk mitigation practices for safe handling of
engineered nanomaterials in the workplace.
DATES: CDC must receive written comments on or before June 24, 2019.
[[Page 16866]]
ADDRESSES: You may submit comments, identified by Docket No. CDC-2019-
0020 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
Survey of Engineered Nanomaterial Occupational Safety and Health
Practices--New--National Institute for Occupational Safety and Health
(NIOSH), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
As mandated in the Occupational Safety and Health Act of 1970 (Pub.
L. 91-596), the mission of the National Institute for Occupational
Safety and Health (NIOSH) is to conduct research and investigations on
work-related disease and injury and to disseminate information for
preventing identified workplace hazards (Sections 20(a)(1) and (d),
Attachment 1). This dual responsibility recognizes the need to
translate research into workplace application if it is to impact worker
safety and well-being. The goal of this project is to assess the
relevance and impact of NIOSH's contribution to guidelines and risk
mitigation practices for safe handling of engineered nanomaterials in
the workplace. The intended use of this data is to inform NIOSH's
research agenda to enhance its relevance and impact on worker safety
and health in the context of engineered nanomaterials. NIOSH is in the
process of procuring a contractor to perform the work, and is on
schedule to award a contract by summer 2019. NIOSH requests a two year
OMB clearance.
The research under this project will survey companies who
manufacture, distribute, fabricate, formulate, use or provide services
related to engineered nanomaterials. The analysis will describe the
survey sample, response rates, and types of company by industry and
size. Further analysis will focus on identifying the types of
engineered nanomaterials being used in industry and the types of
occupational safety and health practices being implemented. The
analysis will be used to develop a final report which evaluates the
influence of NIOSH products, services, and outputs on industry
occupational safety and health practices.
Under this project, the following activities and data collections
will be conducted:
(1) Company Pre-calls. Sampled companies will be contacted to
identify the person who will complete the survey and to ascertain
whether or not the company handles engineered nanomaterials.
(2) Survey. A web-based questionnaire, with a mail option, will be
administered to companies. The purpose of the survey is to learn
directly from companies about their use of NIOSH materials and their
occupational safety and health practices concerning engineered
nanomaterials.
A sample of 600 companies will be compiled from lists of industry
associations, research reports, marketing databases, and web-based
searches. Of the 600 selected companies we anticipate that 500 will
complete the survey. The company pre-call is expected to require 5
minutes to complete. The survey is expected to require 20 minutes to
complete; including the time it may take respondents to look-up and
retrieve needed information. The estimated annualized burden hours for
the respondents' time to participate in this information collection is
109 hours. There are no costs to the responders other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondents Form name respondents responses per response (in (in hours)
respondent hours)
----------------------------------------------------------------------------------------------------------------
Receptionist.................. Pre-call........ 300 1 5/60 25
Occupational Health and Safety Survey.......... 100 1 20/60 34
Specialist.
Industrial Production Managers Survey.......... 75 1 20/60 25
Natural Science Managers...... Survey.......... 75 1 20/60 25
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 109
----------------------------------------------------------------------------------------------------------------
[[Page 16867]]
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2019-08149 Filed 4-22-19; 8:45 am]
BILLING CODE 4163-18-P